Exciting Developments Ahead Revolutionizing Diabetes Care
in the Pipeline for a Healthier
Future!

Innovative Solutions on the Horizon

The Diabetes Pipeline represents a comprehensive approach to advancing diabetes care and management through cutting-edge research and development. We are actively exploring new therapies, technologies, and preventative measures aimed at improving outcomes for individuals affected by diabetes. From novel medications to state-of-the-art screening tools, our pipeline focuses on innovation and accessibility, ensuring that effective solutions are available to those in need. Together, we can pave the way for a future where diabetes is better managed and prevented.

ASSET

INDICATION

DISCOVERY

PRECLINICAL

PHASE I/II

PARTNERSHIPS

SGt2d

Prevention of Type 2 Diabetes 

Wholly owned

SGcrc

Wholly owned

SGcad

Wholly owned

SGd

Wholly owned

SGibd

Wholly owned

Type 1 Diabetes

Type 1 Diabetes is a metabolic disease when the beta cells in pancreas cannot produce insulin resulting in increase blood sugar 

Type 2 Diabetes

Type 2 Diabetes is a metabolic disease when the insulin dose not function properly due to insulin resistance resulting in increase blood sugar level.

Cardio Metabolic Diseases

Cardio metabolic diseases is a group of conditions that include heart attack, stroke, diabetes, kidney disease, and non-alcoholic fatty liver disease. 

Neurodegenerative diseases

Neurodegenerative diseases are disorders characterized by the progressive loss of neurons, leading to cognitive and motor impairments. Alzheimer’s and Parkinson’s diseases are common examples, significantly affecting daily life. Research continues to explore their complex causes and develop effective treatments.

Integrated Approach

A holistic approach to these areas recognizes their interconnections. For example, diabetes management can improve cardiovascular health, which may, in turn, reduce the risk of neurodegenerative diseases. Research into shared risk factors, such as inflammation and oxidative stress, may lead to comprehensive treatment strategies that address multiple conditions simultaneously, enhancing overall patient outcomes. This integrated focus can also inspire new therapeutic targets and public health initiatives aimed at preventing and managing these prevalent health issues.